| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 24 |
| 1 | PANTOPRAZOLE | 14 |
| 2 | ARIPIPRAZOLE | 13 |
| 3 | ADALIMUMAB | 12 |
| 4 | DIVALPROEX SODIUM | 12 |
| 5 | METHOTREXATE SODIUM | 12 |
| 6 | ERGOCALCIFEROL | 11 |
| 7 | INFLIXIMAB | 11 |
| 8 | METHOTREXATE | 11 |
| 9 | ANAKINRA | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SULFACETAMIDE SODIUM | 1 | 0.0020 |
| 1 | ZILEUTON | 1 | 0.0015 |
| 2 | ESTRADIOL ACETATE | 1 | 0.0013 |
| 3 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 3 | 0.0011 |
| 4 | ELIGLUSTAT | 1 | 0.0006 |
| 5 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 6 | EFINACONAZOLE | 1 | 0.0005 |
| 7 | HYDROCORTISONE SODIUM SUCCINATE | 2 | 0.0005 |
| 8 | CEFADROXIL | 1 | 0.0005 |
| 9 | ANAKINRA | 8 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 2 | Interleukin-1 Receptor Antagonist [EPC] | 8 | 0.0005 |
| 3 | Provitamin D2 Compound [EPC] | 11 | 0.0004 |
| 4 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 5 | Integrin Receptor Antagonist [EPC] | 9 | 0.0001 |
| 6 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 3 | 0.0001 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 8 | Insulin [EPC] | 3 | 0.0001 |
| 9 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |